ES2052065T3 - Formulacion dispersable. - Google Patents

Formulacion dispersable.

Info

Publication number
ES2052065T3
ES2052065T3 ES89810772T ES89810772T ES2052065T3 ES 2052065 T3 ES2052065 T3 ES 2052065T3 ES 89810772 T ES89810772 T ES 89810772T ES 89810772 T ES89810772 T ES 89810772T ES 2052065 T3 ES2052065 T3 ES 2052065T3
Authority
ES
Spain
Prior art keywords
dispersible formulation
dispersible
formulation
disintegrant
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810772T
Other languages
English (en)
Spanish (es)
Inventor
Lorraine Mary Murphy
Graham Paul Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2052065T3 publication Critical patent/ES2052065T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES89810772T 1988-10-18 1989-10-10 Formulacion dispersable. Expired - Lifetime ES2052065T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888824392A GB8824392D0 (en) 1988-10-18 1988-10-18 Dispersible formulation

Publications (1)

Publication Number Publication Date
ES2052065T3 true ES2052065T3 (es) 1994-07-01

Family

ID=10645384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810772T Expired - Lifetime ES2052065T3 (es) 1988-10-18 1989-10-10 Formulacion dispersable.

Country Status (19)

Country Link
EP (1) EP0365480B1 (fr)
JP (1) JP2795924B2 (fr)
KR (1) KR0151131B1 (fr)
AT (1) ATE79538T1 (fr)
AU (1) AU626924B2 (fr)
CA (1) CA2000763C (fr)
DE (1) DE68902531T2 (fr)
DK (1) DK170793B1 (fr)
ES (1) ES2052065T3 (fr)
FI (1) FI94925C (fr)
GB (1) GB8824392D0 (fr)
GR (1) GR3006304T3 (fr)
IE (1) IE62557B1 (fr)
IL (1) IL91949A (fr)
NZ (1) NZ231023A (fr)
PH (1) PH30526A (fr)
PT (1) PT92002B (fr)
SA (1) SA90100079B1 (fr)
ZA (1) ZA897853B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059260B1 (es) 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE69733476T2 (de) * 1996-06-14 2006-03-23 Kyowa Hakko Kogyo Co., Ltd. Im munde schnellzerfallende tablette
EP0839526A3 (fr) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Préparation pharmaceutique solide à dissolution ou désintégration buccale rapide
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
EP2263660B1 (fr) 1998-05-18 2017-09-27 Takeda Pharmaceutical Company Limited Comprimé se désintégrant dans la bouche
AU753241C (en) * 1998-06-11 2003-05-08 Pharmacia & Upjohn Company Tablet formation
DE69942777D1 (de) 1998-07-28 2010-10-28 Takeda Pharmaceutical Leicht zerfallende feste Zubereitung
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
WO2013156163A1 (fr) 2012-04-19 2013-10-24 Glatt Ag Compositions pharmaceutiques au goût masqué contenant du diclofénac
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
CH675537A5 (fr) * 1988-03-25 1990-10-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
GR3006304T3 (fr) 1993-06-21
DE68902531D1 (de) 1992-09-24
IE62557B1 (en) 1995-02-08
IL91949A0 (en) 1990-06-10
FI94925C (fi) 1995-11-27
ZA897853B (en) 1992-07-29
ATE79538T1 (de) 1992-09-15
EP0365480A1 (fr) 1990-04-25
JPH02164824A (ja) 1990-06-25
FI894899A0 (fi) 1989-10-16
EP0365480B1 (fr) 1992-08-19
DK515489A (da) 1990-04-19
NZ231023A (en) 1991-09-25
DK170793B1 (da) 1996-01-22
DE68902531T2 (de) 1993-04-08
CA2000763A1 (fr) 1990-04-18
SA90100079B1 (ar) 1999-03-21
AU4297089A (en) 1990-04-26
DK515489D0 (da) 1989-10-17
IL91949A (en) 1993-08-18
PT92002A (pt) 1990-04-30
PH30526A (en) 1997-06-13
IE893336L (en) 1990-04-18
KR900005964A (ko) 1990-05-07
PT92002B (pt) 1995-06-30
FI94925B (fi) 1995-08-15
JP2795924B2 (ja) 1998-09-10
GB8824392D0 (en) 1988-11-23
KR0151131B1 (ko) 1998-10-15
CA2000763C (fr) 2000-11-14
AU626924B2 (en) 1992-08-13

Similar Documents

Publication Publication Date Title
ES2052065T3 (es) Formulacion dispersable.
FI935675A0 (fi) Pyrazolopyrimidiner
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
TW273550B (fr)
NO924172D0 (no) Substituerte bifenylpyridoner
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
GR3033856T3 (en) Novel structural analogues of vitamin d
ATE121295T1 (de) Augentropfenarzneimittel.
ATE122348T1 (de) Antipsychotische 3-piperazinylbenzazolderivate.
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
GR3004863T3 (fr)
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
GR3031360T3 (en) Composition based on ibuprofen, for oral usage
ITMI911841A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associaate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911842A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911713A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365480

Country of ref document: ES